Literature DB >> 6201722

Adenovirus VA RNAI: a positive regulator of mRNA translation.

C Svensson, G Akusjärvi.   

Abstract

We have developed a sensitive transient expression assay in 293 cells to study the effect of VA RNAs on the translation of adenovirus mRNAs. Monolayers of 293 cells were transfected with mixtures of recombinant plasmids encoding adenovirus-specific transcription units and plasmids encoding VA RNAs. Transfected cells were labeled with [35S]methionine for ca. 15 h, and labeled cell extracts were prepared. Changes in the protein expression caused by VA RNA cotransfection were measured by immunoprecipitation, using monospecific antisera prepared against adenovirus-specific polypeptides. Using this experimental design, we demonstrate that VA RNAI stimulates the translation of both early and late adenovirus mRNAs. Synthesis of the E3 19,000-dalton glycoprotein and the E2A 72,000-dalton DNA binding protein was stimulated between 10 and 20 times by VA RNAI cotransfection. Synthesis of the late hexon polypeptide was also stimulated, although translation of hexon was from an aberrant mRNA lacking the second and third segments of the common tripartite leader attached to late adenovirus mRNAs. VA RNAII, although very homologous to VA RNAI, does not function as a translational stimulator.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201722      PMCID: PMC368790          DOI: 10.1128/mcb.4.4.736-742.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

Authors:  G A Beltz; S J Flint
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

2.  Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293).

Authors:  L Aiello; R Guilfoyle; K Huebner; R Weinmann
Journal:  Virology       Date:  1979-04-30       Impact factor: 3.616

3.  Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus.

Authors:  M R Lerner; J A Boyle; J A Hardin; J A Steitz
Journal:  Science       Date:  1981-01-23       Impact factor: 47.728

4.  Adenovirus early gene products may control viral mRNA accumulation and translation in vivo.

Authors:  H Persson; H J Monstein; G Akusjärvi; L Philipson
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

5.  Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome.

Authors:  J Hérissé; G Courtois; F Galibert
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

6.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

7.  Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2.

Authors:  G Akusjärvi; M B Mathews; P Andersson; B Vennström; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  Transcriptional control regions of the adenovirus VAI RNA gene.

Authors:  D M Fowlkes; T Shenk
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

9.  Construction of restriction enzyme fragment libraries containing DNA from human adenovirus types 2 and 5.

Authors:  A Stenlund; M Perricaudet; P Tiollais; U Pettersson
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

10.  Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.

Authors:  M R Lerner; N C Andrews; G Miller; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  34 in total

1.  In vitro transcription complementation assay with miniextracts of transiently transfected COS-1 cells.

Authors:  H P Gerber; O Georgiev; K Harshman; W Schaffner
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Suppression of RNA interference by adenovirus virus-associated RNA.

Authors:  M Gunnar Andersson; P C Joost Haasnoot; Ning Xu; Saideh Berenjian; Ben Berkhout; Göran Akusjärvi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function.

Authors:  G D Ghadge; S Swaminathan; M G Katze; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection.

Authors:  Megan E Spurgeon; David A Ornelles
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

7.  Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter.

Authors:  M Bondesson; K Ohman; M Manervik; S Fan; G Akusjärvi
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions.

Authors:  M P Quinlan; D M Knipe
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

9.  Functional dissection of adenovirus VAI RNA.

Authors:  M R Furtado; S Subramanian; R A Bhat; D M Fowlkes; B Safer; B Thimmappaya
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

10.  Adenovirus uncoating and nuclear establishment are not affected by weak base amines.

Authors:  E Rodríguez; E Everitt
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.